Company page

Novocure Limited

Novocure Limited is a public company traded under the ticker NVCR in the American market, with a market capitalization of approximately $1.65 billion. The company is focused on developing innovative therapies for cancer treatment. Novocure's flagship product utilizes its proprietary Tumor Treating Fields technology to target and disrupt cancer cell division.